Landgraf Rainer, Wigger Alexandra
Max Planck Institute of Psychiatry, Munich, Germany.
Behav Genet. 2002 Sep;32(5):301-14. doi: 10.1023/a:1020258104318.
In addition to their robust difference in trait anxiety, as illustrated by a variety of behavioral tests, HAB and LAB rats differ in their stress coping strategies, the former being more susceptible and vulnerable to stressor exposure and preferring more passive strategies. HAB rats of either gender show signs of a hyper-reactive hypothalamic-pituitary-adrenocortical (HPA) axis, thus resembling psychiatric patients. As shown by in situ hybridization and microdialysis in freely behaving animals, both the expression and release of vasopressin in the hypothalamic paraventricular nucleus are higher in HAB than in LAB rats, thus contributing to the HPA axis hyperdrive. Accordingly, in HAB animals, administration of a V1 receptor antagonist normalized the pathological outcome of the dexamethasone/corticotropin-releasing hormone test and triggered behavioral changes toward reduced anxiety and active stress coping. Pharmacological validation has revealed signs of depressive-like behavior, as HAB but not LAB rats have shown more active stress coping behavior and a normalized HPA axis after treatment with paroxetine. Of interest, this antidepressant reduced the hypothalamic overexpression of vasopressin; this novel mechanism of action is likely to contribute to paroxetine effects on both behavioral and neuroendocrine parameters. Cross-mating and cross-fostering paradigms showed that the divergent emotionality in HAB vs. LAB rats is determined genetically, rather than postnatally through maternal behavior. As the behavioral and neuroendocrine phenotyping pointed to the vasopressin gene as a candidate gene critically involved in anxiety, preliminary genetic approaches have been focused on this gene, revealing single nucleotide polymorphisms (SNPs) in the promotor area of the vasopressin gene in HAB, but not LAB rats. HAB/LAB rats are thus proving to be a unique animal model to identify and characterize neurobiological, neuroendocrine, and genetic correlates of trait anxiety, and perhaps depression, in humans.
除了通过各种行为测试所表明的在特质焦虑方面存在显著差异外,高焦虑易感性(HAB)大鼠和低焦虑易感性(LAB)大鼠在应激应对策略上也有所不同,前者对应激源暴露更敏感、更脆弱,且更喜欢采用更被动的策略。两种性别的HAB大鼠均表现出下丘脑 - 垂体 - 肾上腺皮质(HPA)轴反应过度的迹象,因此类似于精神疾病患者。在自由活动的动物中进行的原位杂交和微透析显示,HAB大鼠下丘脑室旁核中加压素的表达和释放均高于LAB大鼠,从而导致HPA轴过度驱动。因此,在HAB动物中,给予V1受体拮抗剂可使地塞米松/促肾上腺皮质激素释放激素试验的病理结果正常化,并引发行为改变,使焦虑减轻且应激应对变得积极。药理学验证显示出类似抑郁行为的迹象,因为HAB大鼠而非LAB大鼠在用帕罗西汀治疗后表现出更积极的应激应对行为且HPA轴正常化。有趣的是,这种抗抑郁药降低了下丘脑加压素的过度表达;这种新的作用机制可能有助于解释帕罗西汀对行为和神经内分泌参数的影响。交叉交配和交叉寄养实验表明,HAB大鼠与LAB大鼠之间不同的情绪反应是由基因决定的,而非通过产后的母性行为决定。由于行为和神经内分泌表型分析表明加压素基因是与焦虑密切相关的候选基因,初步的遗传学研究方法已聚焦于该基因,结果显示HAB大鼠而非LAB大鼠的加压素基因启动子区域存在单核苷酸多态性(SNP)。因此,HAB/LAB大鼠正被证明是一种独特的动物模型,可用于识别和表征人类特质焦虑以及可能的抑郁症的神经生物学、神经内分泌和遗传相关性。